SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CRBP

Corbus Pharmaceuticals Holdings, Inc.
NASDAQHealth Care

Latest close: 4.52 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 14, 2026Reported sale · Form 4Yong Ben · $15.7KOpen the filing ↗
  3. Sep 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record76412 flagged findings
Reported transactions (Form 4)80since May 16, 2024 · and 8 other holdings
Corporate events (8-K)30since Aug 18, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

1 reverse split in 5 years (1:30 on Feb 14, 2023) · 1:30 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 764)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Communication to the market new
  • Sep 30, 26SCHEDULE 13G ↗Passive stake · RA Capital Management, L.P. · 9.9% · event on Sep 23, 26
  • Sep 15, 26Form 4 ↗Insider transaction
  • Sep 14, 268-K ↗Current report · Communication to the market · Other events
  • Aug 17, 26Form 4 ↗Insider transaction
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Citadel Securities LLC · 1.1% · event on Jun 30, 26 · amendment
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Aug 7, 26424B5 ↗Securities offering
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results · Communication to the market
  • Aug 4, 26Form 3 ↗Insider transaction
  • Jul 27, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.9% · event on Jun 30, 26
  • Jul 27, 26Form 144 ↗Notice of proposed sale
  • Jul 6, 268-K ↗Current report · Entered a material agreement
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • May 26, 268-K ↗Current report · Communication to the market · Other events
  • May 22, 26Form 4 ↗Insider transaction
  • May 22, 26Form 3 ↗Insider transaction

764 filings on record, the oldest from Jul 29, 14.

Listing the 25 most recent filings of the 764 on record.

8-Ks, explained

Stress6Structure31Governance36
  • Jul 6, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 21, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • May 14, 26GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Apr 16, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 7, 26GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Dec 18, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 3, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance6 senior executive changes2024 – 2025show all 6hide
    • Mar 21, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 18, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 20, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 20, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 10, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 6, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 1, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 9, 24StressListing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
  • Nov 13, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Governance3 senior executive changes2023show all 3hide
    • Apr 24, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
    • Mar 7, 23GovernanceA senior executive left or was appointed+4 more in the same filing8-K 5.02 ↗
    • Mar 6, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 13, 23StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jan 6, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Oct 31, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

7 older filings not shown · The record reaches back to Apr 22, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Jul 7, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jan 3, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 8, 20StressRestructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Cormorant Asset Management, LP13.4%Dec 11, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • RA Capital Management, L.P.9.9%Sep 23, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Aberdeen Group plc7.5%Dec 31, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.9%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
  • OrbiMed Capital LLC5.9%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 4 more holdershide
  • Octagon Capital Advisors LP5.4%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Kenneth Griffin5.3%Nov 4, 25SCHEDULE 13G ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • The Vanguard Group4.9%Jun 30, 25SCHEDULE 13G/A ↗
  • Citadel Securities LLC1.1%Jun 30, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 7, Stifel, Nicolaus & Company, Inc CIAS /FA filed notice of intent to sell up to $121K. That is about 0.06% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+2 more recent notices

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 14, 26Sell$16KYong Ben↗
  • Aug 11, 26Buy$25KNishant C SaxenaChief Business Officer↗
  • Aug 7, 26Sell$121KSean F. MoranChief Financial Officer↗
  • Aug 7, 26Sell$171KYuval CohenChief Executive Officer↗
  • Jun 10, 26Sell$19KAnne Altmeyer↗
  • Jun 10, 26Sell$38KJohn Kenneth Jenkins↗
  • Jun 10, 26Sell$16KWinston Kung↗
  • Jun 3, 26Buy$68KNishant C SaxenaChief Business Officer↗
  • Jun 2, 26Buy$33KNishant C SaxenaChief Business Officer↗
  • Mar 2, 26Sell$51KDominic SmethurstChief Medical Officer↗
  • Feb 17, 26Sell$6KIan HodgsonChief Operating Officer↗
  • Feb 13, 26Sell$108KYuval CohenChief Executive Officer↗

There are 9 more transactions in this stretch.

Stock compensation, tax and giftsshow the 19 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 16, 26Compensationamount n/aLeonardo Viana NicacioChief Medical Officer↗
  • May 21, 26Compensationamount n/aNishant C SaxenaChief Business Officer↗
  • May 19, 26Compensationamount n/aBrent Pfeiffenberger↗
  • May 19, 26Compensationamount n/aYong Ben↗
  • May 19, 26Compensationamount n/aAnne Altmeyer↗
  • May 19, 26Compensationamount n/aJohn Kenneth Jenkins↗
  • May 19, 26Compensationamount n/aRachelle Suzanne Jacques↗
  • May 19, 26Compensationamount n/aWinston Kung↗
  • Jan 14, 26Compensationamount n/aYuval CohenChief Executive Officer↗
  • Jan 14, 26Compensationamount n/aSean F. MoranChief Financial Officer↗
  • Jan 14, 26Compensationamount n/aDominic SmethurstChief Medical Officer↗
  • Jan 14, 26Compensationamount n/aIan HodgsonChief Operating Officer↗
  • Oct 27, 25Compensation$38KYuval CohenChief Executive Officer↗
  • Oct 24, 25Compensation$55KSean F. MoranChief Financial Officer↗
  • Oct 24, 25Compensation$79KYuval CohenChief Executive Officer↗
  • Oct 20, 25Compensation$5KAnne Altmeyer↗
  • May 30, 25Compensationamount n/aRachelle Suzanne Jacques↗
  • May 30, 25Compensationamount n/aALAN F HOLMER↗
  • May 30, 25Compensationamount n/aAnne Altmeyer↗

The full record holds 119 transactions and goes back to Feb 13, 23.

Its sector and its market

Corbus Pharmaceuticals Holdings, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Corbus Pharmaceuticals Holdings, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Corbus Pharmaceuticals Holdings, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
764 documents on file, from Jul 29, 2014 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.